Transplant stories

Real Treatments. Real Families. Real Hope.

Smart Cells was the first private UK stem cell bank to release samples for transplant — proving that family cord blood banking is not just about storage, but about delivering real therapies when they are needed most.

Why Stem Cell Transplants Matter

At some point in life, your child or family member may need access to stem cell therapy. Today, these treatments are being used for:

Blood cancers such as leukaemia and lymphoma
Inherited genetic disorders including thalassemia and sickle cell disease
Neurological conditions such as cerebral palsy and brain injury
Immune deficiencies and metabolic disorders
Emerging therapies for sports injuries, inflammatory conditions, and skin repair

By preserving your baby’s umbilical cord blood and tissue, you safeguard access to these life-saving and life-enhancing possibilities.

Proven Track Record

Smart Cells has released more stem cell samples for treatment than any other private UK bank, with a 100% success rate for every sample delivered to clinicians worldwide.

These samples have helped children and families across the globe face illnesses such as:

Cerebral Palsy
Thalassemia
Leukaemia
HSV Encephalitis
Immune system disorders

Each transplant is more than a statistic — it represents a child given new options, and a family given hope.

A Milestone for Families and for Science

Every successful release shows how far the field of stem cell research has advanced. What was once only a possibility is now a proven therapy.

Yet many parents are still unaware of the benefits of storing their baby’s cord blood and tissue. Smart Cells is working to change that — by raising awareness, sharing real transplant stories, and supporting research into the next generation of regenerative treatments.

Powered by FamiCord: Europe’s Stem Cell Leader in banking and use of cells

As part of the FamiCord Group, Europe’s largest family stem cell bank and one of the world’s top three:

Families gain access to 1,000,000+ stored cord blood units across the network
Therapies are supported by specialist research centres and clinical teams in 35+ countries including FamiCord Programme for brain disorders
FamiCordTx, the group’s advanced therapies division, is actively developing new cell-based treatments to extend the possibilities for families everywhere

Together, Smart Cells and FamiCord stand at the forefront of innovation, offering parents confidence today — and hope for tomorrow.

Order now Find out more

FamiCord Group releases

Patients

7800+

Expand table
No.	Source	Source type	Diagnosis	Medical sector	Year of application	Therapy	Country	Age of the recipient
8701	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	47
8702	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	57
8703	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	61
8704	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	44
8705	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	32
8706	Bone Marrow	Autologous	Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	57
8707	Bone Marrow	Autologous	Non St-Elevated Myocardial Infarction	Hematology	2009	Standard Therapy	Germany	56
8708	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2009	Standard Therapy	Germany	24
8709	Apheresis	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2009	Standard Therapy	Germany	43
8710	Apheresis	Autologous	Acute Lymphoblastic Leukemia; Lymphoma – Relapse	Hematology	2009	Standard Therapy	Germany	47
8711	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	42
8712	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	49
8713	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	56
8714	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	57
8715	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	56
8716	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	61
8717	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2009	Standard Therapy	Germany	57
8718	Apheresis	Allogeneic	B-Cell Non-Hodgkin Lymphoma	Hematology	2009	Standard Therapy	Germany	60
8719	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2009	Standard Therapy	Germany	43
8720	Apheresis	Autologous	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2009	Standard Therapy	Germany	61
8721	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2009	Standard Therapy	Germany	47
8722	Apheresis	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2009	Standard Therapy	Germany	49
8723	Apheresis	Autologous	Hodgkin Relapse	Hematology	2009	Standard Therapy	Germany	46
8724	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2009	Standard Therapy	Germany	69
8725	Apheresis	Autologous	Mantle Cell Non-Hodgkin-Lymphoma	Hematology	2009	Standard Therapy	Germany	56
8726	Apheresis	Autologous	Mucosa Associated Lymphoid Tissue/ Diffuse Large Cell Lymphoma	Hematology	2009	Standard Therapy	Germany	55
8727	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	68
8728	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	55
8729	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	51
8730	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	58
8731	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	63
8732	Apheresis	Autologous	Multiple Myeloma	Hematology	2009	Standard Therapy	Germany	63
8733	Apheresis	Allogeneic	Multiple Myeloma; Myelodysplastic Syndrome	Hematology	2009	Standard Therapy	Germany	44
8734	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2009	Standard Therapy	Germany	70
8735	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2009	Standard Therapy	Germany	57
8736	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2009	Standard Therapy	Germany	67
8737	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2009	Standard Therapy	Germany	68
8738	Apheresis	Autologous	Non-Hodgkin-Lymphoma-Relapse	Hematology	2009	Standard Therapy	Germany	46
8739	Apheresis	Autologous	Non-Hodgkin-Lymphoma-Relapse	Hematology	2009	Standard Therapy	Germany	74
8740	Apheresis	Allogeneic	Paroxysmal Nocturnal Hemoglobinuria (Pnh)	Hematology	2009	Standard Therapy	Germany	39
8741	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	63
8742	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	50
8743	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	60
8744	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	49
8745	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	68
8746	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	57
8747	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	53
8748	Apheresis	Autologous	Plasmacytoma	Hematology	2009	Standard Therapy	Germany	64
8749	Apheresis	Allogeneic	Severe Aplastic Anemia	Hematology	2009	Standard Therapy	Germany	55
8750	Apheresis	Allogeneic	Severe Aplastic Anemia And Paroxysmal Nocturnal Hemoglobinuria	Hematology	2009	Standard Therapy	Germany	47
8751	Cord Blood	Allogeneic – Related	Acute Lymphoblastic Leukemia	Hematology	2008	Standard Therapy	Poland	5
8752	Cord Blood	Autologous	Brain Damage	Neurology	2008	Experimental Therapy	Germany	1
8753	Cord Blood	Autologous	Cerebral Ischemia	Neurology	2008	Experimental Therapy	Poland	1,5
8754	Cord Blood	Allogeneic – Related	Thalassemia Major	Hematology	2008	Standard Therapy	Turkey	7
8755	Bone Marrow Family	Allogeneic	Acute Lymphoblastic Leukemia	Hematology	2008	Standard Therapy	Germany	17
8756	Bone Marrow Family	Allogeneic	Chronic Myelogenous Leukemia	Hematology	2008	Standard Therapy	Germany	53
8757	Bone Marrow	Autologous	Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	46
8758	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	60
8759	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	44
8760	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	67
8761	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	58
8762	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	56
8763	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	72
8764	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	69
8765	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	53
8766	Bone Marrow	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	70
8767	Bone Marrow	Autologous	Peripheral Artery Disease	Hematology	2008	Standard Therapy	Germany	76
8768	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	56
8769	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	58
8770	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	70
8771	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	56
8772	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	65
8773	Apheresis	Allogeneic	Acute Myeloid Leukemia	Hematology	2008	Standard Therapy	Germany	38
8774	Apheresis	Allogeneic	B-Cell Non-Hodgkin Lymphoma – Relapse	Hematology	2008	Standard Therapy	Germany	49
8775	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2008	Standard Therapy	Germany	51
8776	Apheresis	Allogeneic	Chronic Lymphocytic Leukemia	Hematology	2008	Standard Therapy	Germany	49
8777	Apheresis	Autologous	Diffuse Large B-Cell Non-Hodgkin-Lymphoma	Hematology	2008	Standard Therapy	Germany	44
8778	Apheresis	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	73
8779	Apheresis	Autologous	Ischemic Cardiomyopathy	Hematology	2008	Standard Therapy	Germany	46
8780	Apheresis	Autologous	Mantle Cell Lymphoma	Hematology	2008	Standard Therapy	Germany	64
8781	Apheresis	Autologous	Morbus Hodgkin	Hematology	2008	Standard Therapy	Germany	25
8782	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	52
8783	Apheresis	Allogeneic	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	45
8784	Apheresis	Autologous	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	61
8785	Apheresis	Autologous	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	58
8786	Apheresis	Autologous	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	67
8787	Apheresis	Autologous	Multiple Myeloma	Hematology	2008	Standard Therapy	Germany	57
8788	Apheresis	Allogeneic	Myelodysplastic Syndrome	Hematology	2008	Standard Therapy	Germany	58
8789	Apheresis	Autologous	Myosarcoma	Hematology	2008	Standard Therapy	Germany	56
8790	Apheresis	Autologous	Non-Hodgkin Lymphoma	Hematology	2008	Standard Therapy	Germany	55
8791	Apheresis	Autologous	Non-Hodgkin-Lymphoma-Relapse	Hematology	2008	Standard Therapy	Germany	65
8792	Apheresis	Allogeneic	Osteomyelofibrosis	Hematology	2008	Standard Therapy	Germany	62
8793	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	68
8794	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	52
8795	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	53
8796	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	67
8797	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	69
8798	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	56
8799	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	59
8800	Apheresis	Autologous	Plasmacytoma	Hematology	2008	Standard Therapy	Germany	52

Page 88 of 89 1 86 87 88 89

Expand table

Stem cell transplantation has become an established procedure

700,000

cord blood collections have been undertaken globally

50,000

hematopoietic stem cell transplants take place every year

400/500

of these transplants are in Europe

Our transplant stories

Smart Cells have released 24 UK
samples to six countries.

Stem cells hold the key to more than 80 life-changing treatments, with clinical trials underway on many more. Replacing damaged cells and tissue, they can even save a child’s life.

100% infusion success rate

For samples released for transplant.

3 months – 12 yrs old

Stored cord blood samples have been successfully released for use in transplant for children aged as little as 3 months to 12 years old.

46% self | 54% siblings

Smart Cells have successfully released stored cord blood samples that have been used for treatment with the child it was collected from and also siblings.

Smart Cells releases

UK samples released

Expand table
Sample release date	Medical condition	Recipient relationship	Age of the recipient	Unit volume	Medical center	Country
2005.11	Thalassemia	Allogeneic (Sibling)	4 Years	144ml	Mount Vernon Hospital	Singapore
2005.11	Leukaemia	Allogeneic (Sibling)	Restricted	Restricted	Stem Cells and Immunology Department, Birmingham	UK
2007.02	Thalassemia	Allogeneic (Sibling)	7 Years	76ml	Kinderlink der Tu Munchen	Germany
2009.08	Cerebral Palsy	Autologous (Self)	3 Years	51ml	Duke University, North Carolina	USA
2010.01	Cerebral Palsy	Autologous (Self)	3 Years	81ml	Duke University, North Carolina	USA
2013.10	Thalassemia	Allogeneic (Sibling)	5 Years	58ml	Catherine Lewis Centre, Hammersmith	UK
2014.01	Leukaemia	Allogeneic (Sibling)	4 Years	71ml	Medizinische Hochschule, Hanover	Germany
2014.05	Cerebral Palsy	Autologous (Self)	1 year	68ml	Duke University, North Carolina	USA
2014.06	HSV Encephalitis & NMDA Receptor Antibody Virus	Autologous (Self)	2 Years	57ml	Duke University, North Carolina	USA
2014.08	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	3 Months	39ml	Duke University, North Carolina	USA
2015.02	Hypoxic Ischemic Encephalopathy (HIE)	Autologous (Self)	6 Months	53ml	Duke University, North Carolina	USA
2015.03	Severe Combined Immune Deficiency	Autologous (Self)	3 Months	74ml	Duke University, North Carolina	USA
2015.03	Sickle Cell Disease	Allogeneic (Sibling)	2 .5 Years	57ml	BLK Hospital, New Delhi	India
2015.11	Thalassemia	Allogeneic (Sibling)	12 Years	87ml	Children’s Hospital of Pittsburgh of UPMC	USA
2016.03	Cerebral Palsy	Allogeneic (Sibling)	6 Years	101ml	Duke University, North Carolina	USA
2017.04	Lymphoblastic Leukaemia (^1)	N/A (Identical twin girls)	Restricted	125ml	Bambin Gesu Childrens’ Hospital, Rome	Italy
2017.06	Cerebral Palsy	Autologous (Self)	7 Years	82ml	Duke University, North Carolina	USA
2017.06	Cerebral Palsy	Autologous (Self)	3.4 Years	132ml	Duke University, North Carolina	USA
2018.03	Autism	Autologous (Self)	5.4 Years	73ml	Duke University, North Carolina	USA
2018.03	Cerebral Palsy	Autologous (Self)	3.4 years	132ml	Duke University, North Carolina	USA
2019.06	Cerebral Palsy	Allogeneic (Sibling)	3 Years	104ml	Duke University, North Carolina	USA
2022.02	Cerebral Palsy	Allogeneic (Sibling)	11 Years	185ml	Duke University, North Carolina	USA
2023.08	Cerebral Palsy	Allogeneic (Sibling)	3 Years	46ml	Duke University, North Carolina	USA
2024.01	Thalassaemia	Allogeneic (Sibling)	8 Years	45ml	Cincinnati Children’s Hospital Medical Center	USA